Dudediligence.

Apimeds Pharmaceuticals US, Inc

APUSAMEX · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$332,521Sep ’24−$311,633Dec ’24−$402,397Mar ’25−$2.7MJun ’25−$1.8MSep ’25−$1.2MDec ’25−$35.1MMar ’26−$20.2MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on file−$747,436−$1.3M−$11.9M
Net incomenone on file−$777,694−$1.4M−$6.0M
Operating cash flownone on file−$627,790−$733,526−$8.9M
Free cash flownone on filenone on filenone on file−$9.0M
Cash$6,171$410,481$3,455$1.6M
Shares outstandingnone on file7.9M7.9M12.6M